ArticleNeoplasia (New York, N.Y.)2008

Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitors.

Toshio Kuwai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.